Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis
Authors:
- 1 April 2006
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 65 (4) , 535-537
Abstract
Objective: To investigate the temporal relationship between onset of inflammation (as measured by secretory phospholipase A2 (sPLA2) and C reactive protein (CRP)) and the presence of autoantibodies (IgM rheumatoid factor (IgM RF) and antibodies against citrullinated peptides (anti-CCP)) in the preclinical phase of rheumatoid arthritis (RA). Methods: For 79 patients with RA who had been blood donors before the onset of disease, a median of 13 serum samples per patient was available. sPLA2 was measured in patient and matched control samples and related to previous CRP, IgM RF, and anti-CCP measurements. The temporal relationship between the increased markers of inflammation and autoantibodies was analysed with time lag analysis. Results: IgM RF and anti-CCP concentrations were significantly associated (p2, CRP, and the combination of sPLA2 and CRP at the same time point. However, we found no stronger association between the two autoantibody tests and the three inflammation measures 1, 2, and 3 years before or after a time point than for measurements at the same time, in the whole group or in subgroups of IgM RF and anti-CCP positive patients. Conclusion: Both the acute phase response and autoantibody formation often develop years before the first symptoms of RA occur, and these phenomena are probably closely connected in time.Keywords
This publication has 7 references indexed in Scilit:
- Increased levels of C‐reactive protein in serum from blood donors before the onset of rheumatoid arthritisArthritis & Rheumatism, 2004
- Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritisClinical and Applied Immunology Reviews, 2004
- Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donorsArthritis & Rheumatism, 2004
- Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritisArthritis & Rheumatism, 2003
- Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritisArthritis & Rheumatism, 2003
- Therapy with interleukin-2 induces the systemic release of phospholipase-A2Cancer Immunology, Immunotherapy, 1995
- Rheumatoid factors antedating clinical rheumatoid arthritis.1991